PharmacyCodes



Relafen en es it fr

Relafen Brand names, Relafen Analogs

Relafen Brand Names Mixture

  • No information avaliable

Relafen Chemical_Formula

C12H12N2O3

Relafen RX_link

http://www.rxlist.com/cgi/generic2/nalidixicacid.htm

Relafen fda sheet

Relafen FDA

Relafen msds (material safety sheet)

Relafen MSDS

Relafen Synthesis Reference

No information avaliable

Relafen Molecular Weight

232.235 g/mol

Relafen Melting Point

229.5 oC

Relafen H2O Solubility

100 mg/L

Relafen State

Solid

Relafen LogP

0.949

Relafen Dosage Forms

Suspension (250 mg/5 mL tsp); Tablets (1000 mg, 500 mg, 250 mg)

Relafen Indication

For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species.

Relafen Pharmacology

Nalidixic acid is a quinolone antibacterial agent for oral administration. Nalidixic acid has marked antibacterial activity against gram-negative bacteria including Enterobacter species, Escherichia coli, Morganella Morganii; Proteus Mirabilis, Proteus vulgaris, and Providencia rettgeri. Pseudomonas species are generally resistant to the drug. Nalidixic acid is bactericidal and is effective over the entire urinary pH range. Conventional chromosomal resistance to nalidixic acid taken in full dosage has been reported to emerge in approximately 2 to 14 percent of patients during treatment; however, bacterial resistance to nalidixic acid has not been shown to be transferable via R factor.

Relafen Absorption

Following oral administration, nalidixic acid is rapidly absorbed from the gastrointestinal tract. Bioavailability is approximately 96%. Absorption may be delayed if taken with antacids.

Relafen side effects and Toxicity

ORAL (LD50): Acute: 1160 mg/kg [Rat]. 572 mg/kg [Mouse]. Toxic psychosis, convulsions, increased intracranial pressure, or metabolic acidosis may occur in patients taking more than the recommended dosage. Vomiting, nausea, and lethargy may also occur following overdosage.

Relafen Patient Information

Relafen Organisms Affected

Enteric bacteria and other eubacteria